The impact of CACNA1C allelic variation on effective connectivity during emotional processing in bipolar disorder

Molecular Psychiatry

Volumn 18, Issue 5, 2013, Pages 526-527

  Radua, J ^a,b   Surguladze, S A ^a,c   Marshall, N ^a   Walshe, M ^a   Bramon, E ^a   Collier, D A ^a   Prata, D P ^a   Murray, R M ^a   McDonald, C ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c ILIA STATE UNIVERSITY   (Georgia)

^d NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN CACNA1C; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ADULT; ALLELE; AMYGDALOID NUCLEUS; BIPOLAR DISORDER; BRAIN REGION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DNA POLYMORPHISM; EMOTION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTELLIGENCE QUOTIENT; LETTER; MALE; MIDDLE FRONTAL GYRUS; PATHOPHYSIOLOGY; PERCEPTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RELATIVE; VISUAL STIMULATION;

ADULT; BIPOLAR DISORDER; BRAIN; CALCIUM CHANNELS, L-TYPE; EMOTIONS; FAMILY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MONTE CARLO METHOD; NEURAL PATHWAYS; POLYMORPHISM, GENETIC;

EID: 84876671670     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.61     Document Type: Letter

References (10)

1. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K et al. Mol Psychiatry 2008; 13: 558-569.
2. Phillips ML, Ladouceur CD, Drevets C. Mol Psychiatry 2008; 13: 833-857.
3. Surguladze SA, Marshall N, Schulze K, Hall MH, Walshe M, Bramon E et al. Neuroimage 2010; 53: 58-64.
4. Roth RB. www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE3526.
5. Sato JR, Fujita A, Cardoso EF, Thomaz CE, Brammer MJ, Amaro Jr E et al. Neuroimage 2010; 52: 1444-1455.
6. Surguladze SA et al. Transl Psychiatry 2012; 2: e70.
7. Strakowski SM, Delbello MP, Adler CM. Mol Psychiatry 2004; 10: 105-116.
8. Jogia J, Ruberto G, Lelli-Chiesa G, Vassos E, Maierú M, Tatarelli R et al. Mol Psychiatry 2011; 16: 1070-1071.
9. Perrier E, Pompei F, Ruberto G, Vassos E, Collier D, Frangou S et al. Eur Psychiatry 2011; 26: 135-137.
10. Sklar P, Ripke S, Scott LJ, Andreassen OA, Cichon S, Craddock N et al. Nat Genet 2011; 43: 977-983.